In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides

Author:  ["Betsy T. Kren","Paramita Bandyopadhyay","Clifford J. Steer"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

A chimeric RNA/DNA oligonucleotide was constructed to induce a sequence mutation in the rat factor IX gene, resulting in prolonged coagulation. Oligonucleotides were targeted to hepato-cytes in cell culture or in vivo by intravenous injection. Nucleotide conversion was both site-specific and dose-dependent. The mutated gene was associated in vivo with significantly reduced factor IX coagulant activity and a marked prolongation of the activated partial thromboplastin time. The results demonstrate that single base-pair alterations can be introduced in hepatocytes in situ by RNA/DNA oligonucleotides, suggesting a potentially powerful strategy for hepatic gene repair without the use of viral vectors.

Cite this article

Kren, B., Bandyopadhyay, P. & Steer, C. In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat Med 4, 285–290 (1998). https://doi.org/10.1038/nm0398-285

View full text

>> Full Text:   In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients

Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxici